FaceIA is a Canadian medical device company in the business of bringing new technology to the artificial intelligence in healthcare industry, specifically to combat detection of rare diseases with an emphasis on genetic diseases. Our company utilizes state-of-the-art technology that will take all collected data, and assess all information through artificial intelligence in order to come to a conclusion or diagnosis. FaceIA’s mission is to expedite and improve accuracy in the diagnostic process for rare diseases in infants and children. We strive to ensure all of those affected by these diseases are diagnosed in a timely manner, so they receive the treatment they need when they need it. FACEIA uses artificial intelligence to reliably diagnose rare genetic diseases quickly through image analysis. Our technology uses facial analysis to detect characteristics of diseases that cause abnormalities in facial features. Our neural network automatically combines facial photos with the patient's personal data along with their genetic data.